These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24520540)

  • 1. Modulation of immune response in experimental Chagas disease.
    Basso B
    World J Exp Med; 2013 Feb; 3(1):1-10. PubMed ID: 24520540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
    Basso B; Marini V
    Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental Chagas disease. Innate immune response in Balb/c mice previously vaccinated with Trypanosoma rangeli. I. The macrophage shows immunological memory: Reality or fiction?
    Basso B; Marini V
    Immunobiology; 2014 Apr; 219(4):275-84. PubMed ID: 24321621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
    Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C
    Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular Vesicles Shed By
    Lovo-Martins MI; Malvezi AD; Zanluqui NG; Lucchetti BFC; Tatakihara VLH; Mörking PA; de Oliveira AG; Goldenberg S; Wowk PF; Pinge-Filho P
    Front Immunol; 2018; 9():896. PubMed ID: 29755471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterologous Chimeric Construct Comprising a Modified Bacterial Superantigen and a Cruzipain Domain Confers Protection Against
    Antonoglou MB; Sánchez Alberti A; Redolfi DM; Bivona AE; Fernández Lynch MJ; Noli Truant S; Sarratea MB; Iannantuono López LV; Malchiodi EL; Fernández MM
    Front Immunol; 2020; 11():1279. PubMed ID: 32695105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice.
    Bryan MA; Guyach SE; Norris KA
    PLoS Negl Trop Dis; 2010 Jul; 4(7):e733. PubMed ID: 20625554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evasion of the Immune Response by Trypanosoma cruzi during Acute Infection.
    Cardoso MS; Reis-Cunha JL; Bartholomeu DC
    Front Immunol; 2015; 6():659. PubMed ID: 26834737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Analysis of the Secretome and Interactome of
    Watanabe Costa R; Batista MF; Meneghelli I; Vidal RO; Nájera CA; Mendes AC; Andrade-Lima IA; da Silveira JF; Lopes LR; Ferreira LRP; Antoneli F; Bahia D
    Front Immunol; 2020; 11():1774. PubMed ID: 32973747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Myeloid-Derived Suppressor Cells to Enhance a Trans-Sialidase-Based Vaccine Against
    Gamba JC; Roldán C; Prochetto E; Lupi G; Bontempi I; Poncini CV; Vermeulen M; Pérez AR; Marcipar I; Cabrera G
    Front Cell Infect Microbiol; 2021; 11():671104. PubMed ID: 34295832
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaccination with Trypanosoma rangeli modulates the profiles of immunoglobulins and IL-6 at local and systemic levels in the early phase of Trypanosoma cruzi experimental infection.
    Marini V; Moretti E; Bermejo D; Basso B
    Mem Inst Oswaldo Cruz; 2011 Feb; 106(1):32-7. PubMed ID: 21340352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive glycoprofiling of the epimastigote and trypomastigote stages of Trypanosoma cruzi.
    Alves MJ; Kawahara R; Viner R; Colli W; Mattos EC; Thaysen-Andersen M; Larsen MR; Palmisano G
    J Proteomics; 2017 Jan; 151():182-192. PubMed ID: 27318177
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Gupta S; Salgado-Jiménez B; Lokugamage N; Vázquez-Chagoyán JC; Garg NJ
    Front Immunol; 2019; 10():1456. PubMed ID: 31293599
    [No Abstract]   [Full Text] [Related]  

  • 14. The induction of host cell autophagy triggers defense mechanisms against Trypanosoma cruzi infection in vitro.
    Duque TLA; Siqueira MS; Travassos LH; Moreira OC; Bozza PT; Melo RCN; Henriques-Pons A; Menna-Barreto RFS
    Eur J Cell Biol; 2020 Jan; 99(1):151060. PubMed ID: 31812279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine responses in Trypanosoma cruzi-infected children in Paraguay.
    Samudio M; Montenegro-James S; Cabral M; Martinez J; Rojas de Arias A; James MA
    Am J Trop Med Hyg; 1998 Jan; 58(1):119-21. PubMed ID: 9452302
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Volpini X; Ambrosio LF; Fozzatti L; Insfran C; Stempin CC; Cervi L; Motran CC
    Front Immunol; 2018; 9():859. PubMed ID: 29743880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response and Trypanosoma cruzi infection in Trypanosoma rangeli-immunized mice.
    Basso B; Moretti ER; Vottero-Cima E
    Am J Trop Med Hyg; 1991 Apr; 44(4):413-9. PubMed ID: 1828328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with Trypanosoma rangeli induces resistance of guinea pigs to virulent Trypanosoma cruzi.
    Basso B; Moretti E; Fretes R
    Vet Immunol Immunopathol; 2014 Jan; 157(1-2):119-23. PubMed ID: 24275040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of IFN-γ coding plasmid supplementation in the immune response and protection elicited by Trypanosoma cruzi attenuated parasites.
    Pérez Brandán C; Mesías AC; Parodi C; Cimino RO; Pérez Brandán C; Diosque P; Basombrío MÁ
    BMC Infect Dis; 2017 Nov; 17(1):732. PubMed ID: 29178839
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.